Zymeworks (ZYME) Operating Expenses (2021 - 2026)

Zymeworks has disclosed Operating Expenses across 6 years of filings, most recently posting $49.5 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at $49.5 million, down 6.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $195.3 million (down 10.53% YoY), and the FY2025 annual result was $198.5 million, down 6.98% from the prior year.
• Operating Expenses came in at $49.5 million for Q1 2026 at Zymeworks, up from $46.7 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $83.1 million in Q4 2022 to a low of $40.3 million in Q4 2023.
• The 5-year median for Operating Expenses is $52.7 million (2025), against an average of $56.3 million.
• Across the five-year window, Operating Expenses soared 36.86% in 2022 and slumped 51.45% in 2023, its largest moves.
• Zymeworks' Operating Expenses stood at $83.1 million in 2022, then plunged by 51.45% to $40.3 million in 2023, then surged by 31.98% to $53.2 million in 2024, then dropped by 12.36% to $46.7 million in 2025, then rose by 6.13% to $49.5 million in 2026.
• The last three Operating Expenses figures came in at $49.5 million (Q1 2026), $46.7 million (Q4 2025), and $49.7 million (Q3 2025), per Business Quant data.